Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase
Journal of Chemical Information and Modeling · 2024
DOI: 10.1021/acs.jcim.4c00344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2024. Verfasst von Christian Seitz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Enzyme Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: University of California, Davis, Health Research Council of New Zealand, Royal Society Te Aparangi.
Abstract (Originalsprache)
Discovered in the 1920s, cytochrome bd is a terminal oxidase that has received renewed attention as a drug target since its atomic structure was first determined in 2016. Only found in prokaryotes, we study it here as a drug target for Mycobacterium tuberculosis (Mtb). Most previous drug discovery efforts toward cytochrome bd have involved analogues of the canonical substrate quinone, known as Aurachin D. Here, we report six new cytochrome bd inhibitor scaffolds determined from a computational screen and confirmed on target activity through in vitro testing. These scaffolds provide new avenues for lead optimization toward Mtb therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
- Department of Chemical Engineering, University of California, Davis, Davis, California 95616, United States.
- Department of Microbiology and Immunology, University of Otago, Dunedin 9016, New Zealand.
- Department of Biochemistry, University of Otago, Dunedin 9016, New Zealand.
- Department of Pharmacology, University of California, San Diego, La Jolla, California 92093, United States.
ORCID-Profile: Christian Seitz, Surl-Hee Ahn, Haixin Wei, J Andrew McCammon
Förderung
- University of California, Davis
- Health Research Council of New Zealand
- Royal Society Te Aparangi
- Marsden Fund
- National Science Foundation
Zitieren
APA
Seitz, C., Ahn, S. H., Wei, H., Kyte, M., Cook, G. M., Krause, K. L., & McCammon, J. A. (2024). Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.4c00344
Vancouver
Seitz C, Ahn SH, Wei H, Kyte M, Cook GM, Krause KL, et al. Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase. Journal of Chemical Information and Modeling. 2024. doi:10.1021/acs.jcim.4c00344
BibTeX
@article{Seitz2024,
author = {Seitz, Christian and Ahn, Surl-Hee and Wei, Haixin and Kyte, Matson and Cook, Gregory M and Krause, Kurt L and McCammon, J Andrew},
title = {Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
doi = {10.1021/acs.jcim.4c00344}
}
EUVIMED